More UK & Europe News – Page 13
-
NewsHow HIV enters the genome – researchers identify previously unknown mechanism
Researchers have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human genome. A research team identified RNA:DNA hybrids (R-loops) as molecular signposts for the virus.
-
NewsMicrobiotica announces completion of recruitment in its international phase 1b trial of microbiome co-therapy
Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is complete in its advanced melanoma (MELODY-1) trial.
-
NewsBout of cystitis may signal presence of urogenital cancers in middle-aged adults
A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers—which affect parts of the body involved in reproduction and excretion—in middle aged adults, suggests research. The risks seem to be especially high within 3 months of infection.
-
NewsCan microbes be the good guys? New study reveals Hollywood’s blind spot
A new review shows how films — from French Kiss to The Martian — highlight microbes as allies in food, medicine, and even space exploration.
-
NewsMediterranean diet could reduce gum disease, study shows
People living in the UK and following a diet close to the Mediterranean diet are more likely to have better gum health, with potentially lower amounts of gum disease and inflammation. A new study suggests that people not following a Mediterranean-style diet tended to have more severe gum disease, especially if they consumed red meat frequently.
-
NewsResearch identifies immune response that controls Oropouche infection and prevents neurological damage
Research conducted on mice has identified that the rapid response of a specific type of defense cell is essential for controlling Oropouche virus infections and preventing serious neurological damage.
-
NewsCholera kills more people for second consecutive year, while prevention and treatment available
The World Health Organization (WHO) has published its global cholera statistics for 2024, showing an increase in both the number of people who fell sick and died from the disease. Reported cholera cases rose by 5% and deaths by 50% in 2024 compared to 2023.
-
NewsMedications leave lasting mark on the gut microbiome, even years after use
Analysing stool samples and prescription records from over 2,500 Estonian Biobank participants, researchers found that the majority of drugs studied were linked to microbiome changes, with a substantial number of them also showing long-term effects detectable years after patients stopped taking them.
-
NewsMicrobial allies: Bacteria help fight against cancer
An international team of scientists have discovered that microbes associated with tumours produce a molecule that can control cancer progression and boost the effectiveness of chemotherapy.
-
NewsUS COVID-19 school closures were not cost-effective - but other non-pharmaceutical interventions were
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research analysing non-pharmaceutical interventions in the United States.
-
NewsAcross eight Amazon countries, forests on Indigenous lands reduce spread of 27 diseases
New research finds that municipalities in the Amazon region closest to healthy forests on Indigenous lands face less risk from rising cases of two categories of disease: cardiovascular and respiratory diseases due to forest fires and illnesses.
-
NewsIt’s not hopeless: Scientists want to learn lessons from climate change communication to save our soil
Soil scientists have urged us all to play our part in protecting our soil and to heed the lessons learnt from those who have been championing actions to mitigate the effects of climate change.
-
NewsMolecular Sustainable Solutions receives investment from BeAble Capital to boost disinfection and sterilization methods
Molecular Sustainable Solutions, a spin-off from the Universitat Jaume I of Castelló (UJI), secures €186,000 investment from BeAble Capital, a leading Science Equity fund specializing in disruptive scientific technologies.
-
NewsSwitching disease on and off: How a gene switch could help against bacterial infections
Researchers show how bacteria actively switch off their disease-causing mechanisms at high cell density and evade the immune system – a potential key to fighting infections better.
-
NewsJames Hutton Limited awarded almost £39,000 to develop innovation campus
James Hutton Limited, the commercial wing of The James Hutton Institute, has been awarded £38,881 from the Scottish Government to progress a clima-tech and agri-tech innovation campus at its Invergowrie site.
-
NewsLiving cement: scientists turn bacteria-infused cement into energy-storing supercapacitors
By integrating electricity-generating microbes into cement, researchers have created a living supercapacitor that can store electricity and regenerate its capacity. The technology could pave the way for energy-autonomous buildings and infrastructure.
-
NewsDiet rich in vegetable protein and fiber helps maternal and infant health during pregnancy and breastfeeding
A Mediterranean-style diet, rich in fibre, vegetable proteins and healthy fats, benefits maternal health during pregnancy and breastfeeding. It prevents fat accumulation and optimizes the composition of the microbiota in the digestive system.
-
NewsScientists report the first use of CRISPR activation to treat a cardiac disease in mice
Researchers have demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study paves the way for novel targeted therapies for patients with genetic cardiac disorders.
-
NewsDrug-resistant fungus Candidozyma auris confirmed to spread rapidly in European hospitals: ECDC calls for urgent action
The latest ECDC survey shows that case numbers are rising and outbreaks are growing in scale, with several countries reporting ongoing local transmission.
-
NewsA ‘universal’ therapy against the seasonal flu? Antibody cocktail targets virus weak spot
Researchers report that a cocktail of antibodies protected mice—including those with weakened immune systems—from nearly every strain of influenza tested, including avian and swine variants that pose pandemic threats.